ClinConnect ClinConnect Logo
Search / Trial NCT05752214

Quality of Life in Italian Visually Impaired Patients

Launched by AMORE FILIPPO · Feb 21, 2023

Trial Information

Current as of November 06, 2025

Recruiting

Keywords

ClinConnect Summary

This clinical trial is focused on understanding the quality of life for visually impaired patients in Italy. Researchers are studying how visual rehabilitation can help people with vision problems and are also testing a questionnaire called the VA LV VFQ. This questionnaire is designed to measure the impact of visual impairment on daily life, and the study aims to see how well it works in the Italian context.

To participate in this trial, individuals must be at least 18 years old and have a visual condition that requires rehabilitation. Participants will need to understand and agree to join the study by signing a consent form. Unfortunately, those under 18 or with certain cognitive difficulties that make it hard to understand the study won’t be eligible. If you decide to join, you can expect to contribute to important research that could help improve the lives of others with similar visual challenges.

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • Subjects aged 18 years or older, suffering from any visual pathology, who are admitted to specialised visual rehabilitation centres for visual rehabilitation.
  • Ability to understand and sign the informed consent for participation in the study.
  • Exclusion Criteria:
  • Less than 18 years of age.
  • Cognitive impairment that, in the opinion of the investigator, limits understanding of the informed consent or the questionnaire.

About Amore Filippo

Amore Filippo is a dedicated clinical trial sponsor committed to advancing medical research and enhancing patient care through innovative therapeutic solutions. With a strong focus on ethical practices and regulatory compliance, Amore Filippo collaborates with leading researchers and healthcare institutions to conduct high-quality clinical trials across various therapeutic areas. Their mission is to deliver safe and effective treatments by fostering a culture of scientific excellence and patient-centered approaches, ultimately contributing to the betterment of global health outcomes.

Locations

Roma, Italy

Patients applied

0 patients applied

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported

Similar Trials